Immunization, HepB3 in Low income
Low income: Immunization, HepB3 was 70.2% in 2024. ◆ Volatile
Immunization, HepB3 in Low income, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
In 2024, immunization, hepb3 in Low income stood at 70.2%.
Compared with earlier readings it is up 0.9% on the previous year and down 2.0% over ten years.
Over the whole period, immunization, hepb3 in Low income peaked at 74.6% in 2019 and was at its lowest, 0.0%, in 1985.
That places Low income 47th out of 47 groups with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Low income, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.0% | — |
| 1991 | 0.3% | — |
| 1992 | 0.2% | -36.3% |
| 1993 | 1.1% | +458.4% |
| 1994 | 2.7% | +138.2% |
| 1995 | 3.1% | +18.1% |
| 1996 | 3.1% | +0.0% |
| 1997 | 3.1% | +0.0% |
| 1998 | 3.1% | -0.6% |
| 1999 | 3.6% | +14.8% |
| 2000 | 3.8% | +7.1% |
| 2001 | 5.3% | +37.4% |
| 2002 | 16.7% | +215.9% |
| 2003 | 22.6% | +35.5% |
| 2004 | 27.5% | +21.8% |
| 2005 | 32.0% | +16.5% |
| 2006 | 37.8% | +18.0% |
| 2007 | 62.0% | +64.0% |
| 2008 | 64.3% | +3.7% |
| 2009 | 69.3% | +7.7% |
| 2010 | 69.1% | -0.2% |
| 2011 | 70.9% | +2.5% |
| 2012 | 70.0% | -1.2% |
| 2013 | 71.2% | +1.7% |
| 2014 | 71.6% | +0.6% |
| 2015 | 72.3% | +1.0% |
| 2016 | 73.5% | +1.6% |
| 2017 | 74.2% | +1.0% |
| 2018 | 73.9% | -0.3% |
| 2019 | 74.6% | +0.9% |
| 2020 | 72.0% | -3.5% |
| 2021 | 70.0% | -2.8% |
| 2022 | 70.6% | +0.8% |
| 2023 | 69.6% | -1.4% |
| 2024 | 70.2% | +0.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 2.0% | 0.0% | 3.6% | 10 |
| 2000s | 34.1% | 3.8% | 69.3% | 10 |
| 2010s | 72.1% | 69.1% | 74.6% | 10 |
| 2020s | 70.5% | 69.6% | 72.0% | 5 |
More health data for Low income
- Population ages 70-74, female, per capita 0.0051 units per person (2025)
- Population ages 75-79, female, annual growth rate 3.06 % change on previous year (2025)
- Population ages 70-74, male, per capita 0.0041 units per person (2025)
- Population ages 70-74, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, male, annual growth rate 4.11 % change on previous year (2025)
- Population ages 70-74, female, annual growth rate 4.14 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, male, per capita 0.0063 units per person (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hepb3 in Low income?
- Immunization, hepb3 in Low income was 70.2% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Low income?
- The highest recorded value was 74.6% in 2019.
- What is the lowest immunization, hepb3 recorded in Low income?
- The lowest recorded value was 0.0% in 1985.
- How does Low income rank for immunization, hepb3?
- Low income ranks 47th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Low income?
- Over the last ten years it is down 2.0%. The long-run trend across the full record is volatile.
- Where does this Low income data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.